BioSpace News Archive

Clinical Outcomes in Patients with High Recurrence Score® Results Presented Today in Oral Session at ESMO 2019 Congress

Energy solutions company begins second phase of the comprehensive energy savings project

Annexon Biosciences announced encouraging results from a Phase 1b dose-ranging clinical trial to evaluate its anti-C1q antibody, ANX005.

Self Care Catalysts Inc., a patient-driven Real World Evidence, Research, and Digital Therapeutics company is pleased to announce that Nigel Page joins the company as Chief Executive Officer.

The Pershing Square Sohn Cancer Research Alliance announced the opening of applications for its 2020 Prize for Young Investigators in Cancer Research.

Benitec Biopharma Limited announces it has entered into a securities purchase agreement with certain sophisticated and professional investors in the United States to issue 2,800,000 American Depositary Shares, with each ADS representing 20 fully paid ordinary shares, at a purchase price of US$0.70 per ADS, in a registered direct offering.

Trading of American Depository Shares to begin under the ticker symbol “RCEL” on October 1st

Late breaking abstract results presented today at ESMO with chemo-radio sensitizer Debio 1143 present a promising breakthrough strategy to improve the front-line treatment of H&N cancer patients

The National Kidney Foundation Statement about INVOKANA® (Canagliflozin)

Innovative specialty pharmacy manager earns 14th spot on coveted 2019 list